A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new ...

For women at higher risk of breast cancer, there is a proven way to cut the risk in half: take an anti-cancer drug such as ...

Supplementary breast cancer imaging with abbreviated MRI and contrast-enhanced mammography detected more cancers than ...

The 33-year-old was diagnosed with Ductal carcinoma in situ which is an early, non-invasive form of breast cancer where ...

A variety of patient, treatment, and pathologic factors have been reported to be associated with an increased risk of ipsilateral breast tumor recurrence after breast conservation therapy (BCT) for ...

Stage 0, often called “carcinoma in situ”, is the earliest form of cancer ... Research suggests that up to 40 per cent of untreated DCIS cases may eventually develop into invasive breast cancer, ...

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...

Some 300,000 women in the US are diagnosed with invasive breast cancer each year. But an additional 50,000 are diagnosed with “stage zero” breast cancer, also called ductal carcinoma in situ ...

SAN ANTONIO — For patients with so-called “good-risk” ductal carcinoma in situ (DCIS ... tamoxifen reduced their overall risks for invasive recurrence, but not their risks for recurrence ...

Do you need chemo for ductal carcinoma in situ? DCIS is considered a noninvasive or pre-invasive breast cancer. Because the cancer cells haven’t spread beyond the walls of your milk ducts ...